Levity GLP-1 Reviews: Is It Legit, and Is It Worth It in 2026?

By Weight Loss Provider Guide · Last verified: August 13, 2026 Weight Loss Provider Guide is an independent comparison resource for GLP-1 telehealth providers.

Advertising disclosure: We may earn a commission if you start care through some of the links on this page. We earn nothing from Levity. That does not change what we found or what we recommend.

The bottom line, up front

Levity is a traceable telehealth platform with named clinicians and pharmacies, and the Florida licenses we checked were active — and many older Levity GLP-1 reviews describe a product Levity stopped selling in April 2025. Here's what it actually sells today: a $179-a-cycle daily compounded liraglutide injection (that's the "$129 first month" you saw in the ad), plus brand-name Wegovy, Ozempic, and Mounjaro at $1,199 to $1,599 per roughly four-week cycle. Its Saxenda page was marked out of stock when we checked. In February 2026, the FDA sent Levity a warning letter over how it marketed compounded drugs. Levity is a fair fit if you want a low-cost daily injection, you're 18–65, your BMI is 27 or higher, and you live in one of its 35 states. It's a poor fit if you wanted weekly semaglutide, need insurance help, or plan to keep going once your BMI drops below 27 — because Levity says it stops prescribing at that point.

Now the part that surprised us. We opened Levity's own pages side by side and found four different price messages on the same website. We also found a page still live today that uses similar brand-comparison wording to the wording the FDA cited six months ago. And when we compared Levity's Wegovy price with NovoCare's current published Wegovy price, the gap was $1,250 per fill at NovoCare's published price for the 0.25–2.4 mg Wegovy doses.

All of it is below. All of it you can check yourself in about ten minutes.

Levity at a glance

What is Levity, in plain English?

Levity is an online weight-loss platform that connects you to a licensed clinician, who decides whether a prescription is right for you, and then arranges home delivery for one bundled price. Levity says it launched in 2023 and is run by the same team behind ZipHealth, an online pharmacy operating since 2019. You do not need an in-person office visit. The intake, clinician review, check-ins, orders, and support run online.

That model isn't unusual. Dozens of companies do it. What makes Levity worth a careful look is that what it sells changed dramatically in 2025 — and the internet mostly didn't notice.

A quick word on one term you'll see all over this page. A compounded drug is prepared by a pharmacy or clinician for a patient's needs. It is not a generic. It is not FDA-approved. The FDA has not reviewed that finished product for safety, how well it works, or quality before it goes on sale. Compounding can be lawful when the pharmacy, prescription, ingredients, and other federal and state rules are met. It just means the safety net is different from the one behind an FDA-approved box of Wegovy.

Keep that distinction in your back pocket. It explains almost everything that follows.

What GLP-1 medication does Levity actually sell now?

Levity's low-cost option is compounded liraglutide with B12, taken as a once-daily injection at $179 per cycle. Levity says it stopped selling compounded semaglutide on April 30, 2025, and automatically cancelled active subscriptions. It also lists brand-name Wegovy, Ozempic, and Mounjaro at much higher cash prices. Its Saxenda page was live but marked out of stock when we checked.

This is the single most important thing on this page, so let's slow down.

The switch nobody told you about

If you searched "Levity GLP-1 reviews," odds are good you landed on a page telling you Levity sells compounded semaglutide for around $225 a month, weekly. That was true. It isn't anymore.

Here's the timeline we put together from Levity's own pages and the FDA's public record:

The reason this matters is simple. Semaglutide injection is usually taken weekly. Liraglutide is taken daily. Over a full year, daily dosing means 313 more injections than weekly dosing. Nobody should find that out after they've paid.

Why did semaglutide disappear?

Short version: the shortage ended.

For a stretch, semaglutide injection was on the FDA's official drug shortage list. While the shortage applied, certain compounders could make copies without running into the usual "essentially a copy" limits, as long as they still met the other rules that applied to them. When the FDA declared the shortage resolved on February 21, 2025, that shortage-based path wound down — April 22, 2025 for 503A compounders and May 22, 2025 for 503B outsourcing facilities.

Levity's own words to a customer who complained about results, published on its Trustpilot profile, describe not anticipating the harsh effects of the FDA's decision on semaglutide. That's a company acknowledging its product line got pulled out from under it.

Liraglutide was still listed in shortage when semaglutide's shortage was declared resolved. Levity's low-cost offer later became compounded liraglutide.

One more wrinkle worth knowing

The FDA's February 2026 letter says the agency reviewed Levity's site in December 2025 and observed it offering compounded semaglutide and liraglutide products. Levity's own help article says semaglutide sales stopped in April 2025.

We're not going to tell you what that means, because we don't know. It could be a leftover page. It could be an image the FDA saw in a different context. What we can tell you is that two public records don't line up, and if it matters to you, ask Levity directly before you pay.

The full menu, with the label facts attached

That Ozempic and Mounjaro row is worth a second look. Levity's product cards market both around weight loss, but both drugs are FDA-approved for type 2 diabetes, not chronic weight management. A licensed clinician may prescribe a drug off-label when medically appropriate. But you should know which box you're buying — and Zepbound, the separate weight-management brand with the same active ingredient as Mounjaro, is often much cheaper. More on that in a minute.

How much does Levity cost in 2026?

Levity's compounded liraglutide page shows $179 per cycle, or $129 for the first cycle with the code WELCOME. Its listed brand-name options run $1,199 to $1,599 per roughly four-week cycle. But Levity's own pages currently show competing price messages, so the number that controls your purchase is the one on your checkout screen.

The four price messages on one website

We pulled these on the same day, from the same site. All five pages were live.

We did not find any Levity page that explains the gap between the $179 liraglutide article and the $225 all-inclusive help article. The $1,149–$1,599 FAQ range appears to describe brand-name treatments, so that range is not proof that one product has four prices. The unexplained $179-versus-$225 conflict is still real — and you're the one whose card gets charged, so you deserve to see it before you're on the payment screen.

What to do about it: screenshot the price on your checkout page before you click confirm. Not the ad. The checkout page.

The billing detail that quietly costs you a month

Every Levity product card says orders are billed and shipped approximately every four weeks.

Four weeks is not a month. Twelve four-week cycles cover 48 weeks. A year is 52. So a fourth-week subscription can fit thirteen charges into a calendar year, not twelve.

That's not a trick and Levity isn't hiding it — it's printed right on the cards. But almost nobody does the math. So we did:

Our arithmetic, based on Levity's published prices. The 13-cycle column is a budget stress test, not a promise that Levity will bill 13 times. Your actual renewal dates decide.

Look at the liraglutide row. That's $2,098–$2,277 for a year. For a cash-pay program with no insurance fight, that is genuinely reasonable, and we're not going to pretend otherwise.

Now look at the Wegovy row. Hold that thought.

What's included, and what isn't

Levity says the monthly price covers the consultation, the prescription, the medication, shipping, follow-ups, and ongoing clinical support. No separate membership fee. That's a real advantage over programs that stack a $79-a-month membership on top of your medication cost.

Not included: lab work, if your clinician requires it. Levity points people to an outside partner lab and says lab costs aren't covered by the subscription.

Support hours: Monday through Friday, 9 a.m. to 5 p.m. Eastern. If you message on Saturday night, you may not get a reply until Monday. For an emergency, use emergency care — not a provider inbox.

Is Levity's brand-name price a good deal? (No, and here's the math)

Levity lists Wegovy at $1,599 per roughly four-week cycle. NovoCare Pharmacy lists Wegovy 0.25–2.4 mg at $349 per monthly fill after its current starter offer, and Wegovy HD 7.2 mg at $399. That is a $1,250 difference per fill at 0.25–2.4 mg, or $1,200 at 7.2 mg, before you count any separate prescriber or program fee.

This is the part of our research that made us sit up.

We were not looking for it. We were checking Levity's brand prices against the manufacturers' published cash prices as a routine sanity check. Here's what came back:

NovoCare and LillyDirect prices verified August 13, 2026. Eligible patients new to NovoCare's Wegovy or Ozempic offer pay $199 for the first two qualifying starter-dose fills through December 31, 2026. After that, NovoCare lists Wegovy 0.25–2.4 mg at $349 and Wegovy HD 7.2 mg at $399. LillyDirect's $449 rate for higher Zepbound doses requires refilling within 45 days; regular prices are higher if that timing is missed. Terms can change.

Over a year, at 12 charges each:

• Wegovy through Levity: $19,138 for 12 cycles
• Wegovy through NovoCare: about $3,888 for 12 fills under the current two-fill starter offer, using the $349 price for 0.25–2.4 mg after the first two fills
• Difference: about $15,250 before any separate clinical-care fee

If Levity bills you 13 times and NovoCare supplies 13 fills under those same published prices, the gap is about $16,500.

We want to be fair here, so let's say the obvious out loud: manufacturer-direct pharmacy pricing does not replace medical care. You still need a valid prescription and someone to manage your treatment. Levity's price includes clinician review, follow-ups, shipping, and support. That has value.

It does not have $1,250-a-month value.

The thing you should do before you pay anyone

Run your insurance first. It's free and it takes about five minutes.

Levity does not accept insurance. Novo Nordisk's current savings offer says eligible commercially insured patients may pay as little as $25 per fill, subject to coverage, savings caps, and program terms; government insurance is excluded from that offer. So if your plan covers a weight-management drug and you sign up for Levity without checking, you may pay full cash price when a covered route would cost far less.

Check the coverage and prior-authorization path first. Then decide.

🎯 If you came here for brand-name medication

Here's the honest version, including the part that doesn't help us.

Ro is not the cheapest cash path on this page. If your only goal is the lowest possible number and you already have a prescriber, NovoCare Pharmacy or LillyDirect can beat a telehealth membership, and we earn nothing when you use them. Go do it if that's your priority — we'd rather you save the money than click our link.

Ro's current weight-loss pricing page centers FDA-approved medication and lists cash prices at the same levels as NovoCare and LillyDirect, plus a separate Ro Body membership. Its free checker reports coverage for Ozempic pen, Wegovy pen, and Zepbound pen, including whether prior authorization is required. If you join, Ro says its insurance concierge handles that paperwork. That does not guarantee approval, but it gives you a team for the part most people get stuck on.

The Ro Body membership is $39 for month one, then $149 month to month or as low as $74 a month with an annual plan paid upfront. Medication costs extra.

A licensed clinician decides whether treatment is appropriate. Coverage results vary by plan.

Is Levity legit? What we actually verified

Yes — Levity is a traceable telehealth platform, not an anonymous checkout page. We confirmed the Florida records for its named pharmacist and both named pharmacies, and we matched the NPI number on Levity's site to the federal NPI Registry. An NPI is an identifier, not a medical license. "Legitimate," though, is not the same as "FDA-approved," and it is not the same as "right for you."

Too many review pages treat "is it a scam?" as the whole question. It isn't. Plenty of real, licensed companies are the wrong choice for you. So we split it into pieces and checked each one.

The verification ledger

What a license proves — and what it doesn't

We want to be careful here, because "licensed" gets thrown around as if it settles everything.

An active Florida pharmacy license tells you the pharmacy exists and the state has authorized it. That's genuinely worth something. Plenty of GLP-1 sellers online can't clear that bar.

It does not tell you that the specific vial you receive meets every standard, that the pharmacy is licensed in your state, that the marketing on the website is accurate, that someone will answer your email quickly, or that the medication is FDA-approved. Different questions, different answers.

What we could not check

We didn't enroll, pay, or receive medication. So we can't tell you: how fast a clinician responds, whether you speak to a live person or just fill out forms, which pharmacy gets your prescription, what the label says, how the package arrives, or whether cancelling from inside the dashboard is one click or a phone call.

A review page that has not tested a paid account cannot prove those details without dated receipts, screenshots, or a patient label. If it claims otherwise, be skeptical.

Why did the FDA send Levity a warning letter?

On February 20, 2026, the FDA sent Levity a warning letter saying its website made false or misleading claims about its compounded semaglutide and liraglutide products. The FDA said the product photos suggested Levity compounds the drugs itself when it does not, and cited two specific marketing phrases that implied the compounded products had FDA approval. The letter did not order a shutdown, a recall, or announce that anyone was harmed.

We read the letter. Here's exactly what it says, without spin in either direction.

What the FDA objected to

Problem one: the label photos. The compounded products pictured on Levity's site had "Levity" on the label. The FDA's position is that a name on a drug label, without qualification, says that company made the drug. The letter states plainly that Levity is not the compounder of those drugs.

Problem two: two specific phrases. The FDA quoted these directly from Levity's website:

"The same ingredient as Ozempic® + Wegovy®"

"The power of Saxenda®"

The FDA's objection: compounded drugs are not FDA-approved, and claims like these imply they've been approved or evaluated for safety and effectiveness when they have not.

The agency called the products misbranded — a legal term meaning the labeling or advertising is false or misleading, not that the medicine is contaminated or fake. Levity had 15 working days to respond. The letter warns that failing to fix it could lead to legal action "including, without limitation, seizure and injunction."

What the letter did not say

This part matters just as much, and most coverage gets it wrong:

• ❌ No shutdown order
• ❌ No recall
• ❌ No contaminated batch
• ❌ No finding that any patient was harmed
• ❌ No criminal charge
• ❌ No statement that the medication doesn't work

A warning letter is a formal FDA notice of alleged violations and a demand for corrective action. It is serious. It is not a shutdown, a recall, or a final court judgment about the medicine.

Levity wasn't alone

On March 3, 2026, the FDA announced warning letters to 30 telehealth companies over compounded GLP-1 marketing — the second batch in an ongoing crackdown. Levity was one of thirty. That context matters. It doesn't erase Levity's individual letter, but it does mean this was an industry-wide sweep, not a company singled out for unique behavior.

What we found six months later

We wanted to know whether Levity fixed it. So on August 13, 2026, we opened Levity's live compounded liraglutide pricing page and read it line by line.

It still describes the compounded product as containing "the same active ingredient found in Saxenda." The same page also calls liraglutide "clinically proven." That is not the exact phrase the FDA quoted, but it is still a direct comparison between a compounded product and an FDA-approved brand.

We are not lawyers and we are not the FDA. We are not saying this is a new violation — only the FDA can make that call, and there may be context we can't see from outside. What we can tell you is that the FDA's letter specifically cited "The power of Saxenda®" as misleading, and that six months later, a live page on the same site draws a same-active-ingredient comparison between a compounded product and an FDA-approved brand.

In fairness, Levity has a disclaimer at the bottom of that page saying the compounded product is not FDA-approved and has not been reviewed by the FDA for safety, effectiveness, or quality. That part is clear and useful. The same disclaimer also says compounded drugs are "prescribed legally under U.S. federal law." FDA's own wording is narrower: a compounded drug must meet the conditions in section 503A or 503B to qualify for exemptions from parts of federal drug law. Legal status depends on the actual prescription, pharmacy, ingredients, and rules — not just the word "compounded."

And one more thing we checked, because we were already in there

That same Levity pricing page carries three numbered scientific references. We looked all three up.

Two of three citations don't support the sentences they're attached to. The page also claims the added B12 can help reduce side effects, with no citation at all.

You can verify every one of these in about four minutes by clicking the PubMed IDs on Levity's own page. We're not claiming this makes Levity a bad company — sloppy citation happens on a lot of health websites, including ones far bigger than Levity. We're telling you because when you're deciding how much to trust a company's medical claims, knowing that its footnotes don't hold up is exactly the kind of thing you'd want someone to check for you.

We're not putting a sales link after a federal warning letter. Keep going.

What's actually in Levity's contract?

Levity's published terms include a $150 fee to move a prescription before it is issued, no change-of-mind refund under its Terms of Sale, and a 48-hour deadline for later subscription orders. A separate Terms of Use clause caps certain damages tied to use of the website at $500 where the site's limits are not enforceable; it is not written as a blanket cap on every possible medical or product claim. The Terms of Sale also point to English law and English courts.

We read both contracts. Almost nobody does — and that's exactly why we found things.

The fine print ledger

The $150 door fee deserves its own paragraph

Read those two clauses together, because they're on the same website and they say different things.

Levity's Prescription Policy says it honors patient freedom of choice, and that you always have the option to send your prescription to the pharmacy of your choice.

Levity's Cancellation & Transfer Policy says you'll be charged a $150 consultation fee for each prescription transferred — and that you have to request it before your prescription is issued.

So freedom of choice exists, costs $150, and expires the moment your script is written. If you're the kind of person who might want to price-shop your pharmacy later, know that the exit door has a toll booth on it and it closes early.

One caveat, in fairness: the Terms of Use displayed on Levity's site were last revised December 13, 2023. That's before the entire current product line existed. It's possible the $150 fee is outdated. It's also possible it's fully current. Ask before you pay.

Who exactly are you buying from?

This is the strangest thing we found, and we double-checked it three times.

Three company names. Two dispute paths that do not line up — the Terms of Use send most disputes to arbitration in Palm Beach County, Florida, while the Terms of Sale say the contract is governed by English law and points proceedings to the English courts.

The Terms of Sale also reference the UK's Mental Capacity Act 2005 and the UK's Consumer Contracts Regulations 2013 — while a separate clause in the same document says "We only sell to the US."

What we think this probably is: Levity operates in the UK as well as the U.S. Our best read is that someone reused a British contract template for the American site and nobody caught it. That's an administrative mess, not evidence of wrongdoing, and we want to be clear we're not accusing anyone of anything.

But here's why we're telling you anyway. If something goes wrong — a billing dispute, a shipment that never arrives, or another contract problem — you need to know which company is on the other side and which terms control. Right now, Levity's own website does not make that clear. That is not paperwork trivia, and it is yours to weigh, not ours to bury.

Does Levity work in my state?

Levity serves 35 states. It does not serve California, Arizona, North Carolina, Utah, Alabama, Arkansas, Delaware, Idaho, Kansas, Louisiana, Mississippi, New Hampshire, New Mexico, South Carolina, West Virginia, or Washington, D.C.

Levity publishes the states it serves. We worked out the other half.

✅ Levity serves these 35 states: Alaska, Colorado, Connecticut, Florida, Georgia, Hawaii, Illinois, Indiana, Iowa, Kentucky, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nebraska, Nevada, New Jersey, New York, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Dakota, Tennessee, Texas, Vermont, Virginia, Washington, Wisconsin, Wyoming

❌ Levity does not serve these 15 states plus D.C.: Alabama, Arizona, Arkansas, California, Delaware, Idaho, Kansas, Louisiana, Mississippi, New Hampshire, New Mexico, North Carolina, South Carolina, Utah, West Virginia, Washington D.C.

Two things stand out.

California isn't on the list. That's the most populous state in the country. If you're in Los Angeles or San Diego and you got that far into a signup flow before finding out, you wasted your afternoon.

Delaware isn't on the list either — even though Levity's About page lists a Delaware registered-company address.

One more caveat: a state appearing on Levity's general list doesn't guarantee every medication is available there. Prescriber networks and pharmacy licensing vary drug by drug. Confirm for the specific treatment you want, not just the state.

Who can actually use Levity — and who gets cut off?

Levity's posted rules are age 18 to 65 and a BMI of 27 or higher. Levity also says it does not offer maintenance treatment and stops prescribing once your BMI falls below 27. That last rule means the program ends when it works.

That third sentence is the one to sit with.

The three gates

Age and BMI are not the only gates

Levity's posted screening page also says it may be unable to prescribe for people who are pregnant, breastfeeding, trying to become pregnant, taking diabetes medicine other than metformin, using insulin or an insulin pump, or who report certain histories involving eating disorders, pancreatitis, bariatric surgery, thyroid cancer or MEN, kidney, liver or gallbladder disease, uncontrolled mood disorders, glaucoma, seizures, or high blood pressure. That is a summary of Levity's own program screen — not a universal rule for every drug or clinician. Answer the intake honestly and let the clinician apply the right rule to you.

The success penalty

Here's the scenario nobody puts on a sales page.

Say you start at a BMI of 32. The medication works. Eight months in, you've done everything right, and your BMI hits 26.5.

Under Levity's posted policy, that's when Levity stops.

For a lot of people, GLP-1 medication isn't a sprint — it's ongoing treatment. Trials of FDA-approved semaglutide and tirzepatide found substantial weight regain after treatment was withdrawn. That does not prove what will happen to every person, and it does not test Levity's compounded product. But if you're planning for the long haul, you need to know now that this program has a finish line built in, and that you may be shopping for a new provider at exactly the moment you're most motivated to keep going.

Two important caveats. First, these are Levity's program rules, not universal medical rules. Another licensed clinician may evaluate you differently. Second — and we mean this seriously — do not shade your answers on the intake form to get past a gate. The questionnaire is a key safety check. Lying to it defeats the information your clinician needs to make a safe decision.

🎯 If Levity just disqualified you

You wanted weekly, not daily. That's the most common reason people land here and leave. Levity's cheap option is a once-a-day injection now. If you specifically want a weekly cash-pay compounded route, Embody currently lists weekly GLP-1 injections starting at $79 and weekly GLP-1/GIP injections starting at $129, with shipping and 24/7 care-team messaging if a licensed clinician finds treatment appropriate. Compounded products are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness, or quality.

→ See the full Embody review

You're over 65, under BMI 27, or need long-term maintenance. Levity isn't going to work, and forcing it is a waste of your time. Take two minutes and let us point you somewhere that fits.

→ Get your personalized GLP-1 action plan (free, 60 seconds)

Compounded drugs are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality. They may qualify for federal exemptions only when all applicable compounding conditions are met.

What do real Levity reviews say?

Levity's Trustpilot profile showed 4.1 out of 5 from 2,058 reviews — but only 53 were posted in the previous 12 months. That means 97.4% of the review count sits outside the most recent year. It does not prove which drug every older reviewer used. It does prove that the headline score is a poor stand-in for the current U.S. daily-liraglutide program, especially because the profile is merged and mixes U.S. and U.K. activity. Recent positive examples mention convenience and price. Recent negative examples mention shipping, billing, and limited clinician contact.

That first stat is why we don't think you should trust the star rating.

The number that changes how you read the score

Two thousand reviews sounds like overwhelming evidence. Fifty-three in the last year sounds like something else entirely.

Here's why it matters. Levity says it ended compounded semaglutide sales in April 2025 and moved its low-cost U.S. offer to daily liraglutide. The older review pool spans earlier products, older policies, and both U.S. and U.K. activity. Trustpilot does not tag each review by drug, so nobody can honestly turn the 2,058-review score into a clean rating of the product you can buy today.

The second thing that muddies the score

The same Trustpilot profile lists both U.K. and U.S. contact details, and its company description lists different current product sets for the two markets.

So the 4.1 is a blended profile across different markets and product eras. It is not a clean rating of the daily liraglutide program an American can buy today.

What customers actually say

Three recent Trustpilot examples. Read them as service anecdotes, not a clinical study.

"Convenient, efficient, fairly priced." — Rachel, 5-star review, April 15, 2026

Wanted "more communication with a clinician." — Kelsey, 4-star review, October 22, 2025

One reviewer reported a missed follow-up dose, a double charge, and slow responses. — T Mart, 1-star review, December 24, 2025

These describe individual service experiences. They are not evidence that any medication is safe or effective, and they do not mean your results will be similar.

The review examples cut both ways. Levity's published flat price does not rise with dose, and that is a point in its favor. But a flat price does not protect you from a mistimed shipment or billing mistake, so save every order date and confirmation.

The themes, sorted

What recent positive examples mention: convenient online signup · fair pricing · deliveries that arrived as expected · helpful email support · flat pricing that doesn't climb with dose · no separate membership fee

What recent negative examples mention: shipping and refill delays · slow responses when timing matters · billing and subscription confusion · limited direct clinician contact, including check-ins described as "static and very limited" · disappointment with the daily liraglutide switch

How do you cancel Levity?

Cancelling your Levity subscription stops future orders, but it does not stop an order that has already started processing. Levity recommends submitting your request at least 48 hours before your next scheduled order date. "Cancel anytime" does not mean every charge can be reversed.

This is where people get burned, so keep it simple. You can also compare GLP-1 providers with easier cancellation:

Your cancellation checklist:

1. Open your dashboard and write down your next scheduled order date
2. Submit the cancellation more than 48 hours before that date
3. Use a written channel — email or in-app message, not a phone call
4. Screenshot the confirmation with the timestamp visible
5. Confirm both that the subscription is cancelled and that no order is pending
6. Ask for written confirmation and save it

We haven't tested Levity's cancellation flow from inside a paid account, so we can't tell you whether it's one button or a phone tree. Anyone claiming to know that without having been a customer is guessing.

Is Levity's compounded liraglutide the same thing as Saxenda?

No. Saxenda is a specific FDA-approved liraglutide product with an approved label, an approved manufacturing process, and an approved delivery device. Levity's compounded liraglutide with B12 is a different product that the FDA has not approved or reviewed for safety, effectiveness, or quality.

This is the exact confusion the FDA's warning letter was about, so it's worth getting right.

What "FDA-approved" actually applies to

The FDA approves specific finished drug products for specific uses. Our guide to how GLP-1 drugs get FDA approval explains that line. It does not approve a molecule in the abstract, and it does not approve a telehealth website. States license pharmacies; FDA separately registers and oversees 503B outsourcing facilities, but that is not the same as FDA approval of a compounded drug.

So there is no such thing as an "FDA-approved telehealth company," and calling a pharmacy "FDA-approved" blurs registration or oversight with approval of a finished drug. When you see that phrasing online, slow down and check what was actually approved.

And a compounded drug is not a generic. A generic goes through an FDA approval process proving it matches the brand. A compounded drug doesn't.

Side by side

Why the strength question is not a nitpick

The FDA has documented dosing errors with compounded injectable semaglutide, including people confusing units with milligrams or milliliters and drawing the wrong volume. That alert was not a finding about Levity's liraglutide. The lesson still applies: compounded concentrations and syringe instructions can differ, so the label math has to be clear.

If you go this route, with any provider, get these in writing before your first injection:

• The exact concentration in mg/mL
• Your prescribed dose in milligrams
• What that dose equals in units or mL on the syringe you were sent
• The syringe size included
• The beyond-use date (when it expires)
• Storage instructions
• Who to call after hours

Your prescriber and pharmacist should give you all of this without you having to push. If getting a straight answer is hard, that itself is information.

Levity pros and cons

Levity's real advantages are a genuinely low cash price for its daily compounded option, flat pricing that doesn't rise with your dose, no membership fee, and publicly verifiable pharmacy licenses. Its real drawbacks are daily injections, a non-FDA-approved compounded product, conflicting public prices, a February 2026 FDA warning letter, and no treatment once your BMI drops below 27.

✅ What Levity genuinely does well

• $179/month for the compounded liraglutide program is competitive for cash-pay
• Your price doesn't go up when your dose goes up — a real differentiator
• No separate membership fee stacked on top of medication
• Everything bundled: consult, medication, shipping, support, follow-ups
• Names its pharmacist, physician, and both pharmacies; the pharmacist and pharmacy license numbers and the physician's NPI are checkable
• Publishes a clear, honest disclaimer about compounded drugs not being FDA-approved
• Its FAQ names serious risks, including the boxed warning for thyroid C-cell tumors and NAION (a rare cause of sudden vision loss)
• Real customer footprint — over 2,000 reviews, not a brand-new shell

❌ What should give you pause

• The budget product is a daily injection, not weekly
• The compounded product is not FDA-approved and hasn't been FDA-reviewed
• Conflicting all-inclusive price messages across live pages: $179 and $225; brand-name range $1,149–$1,599
• Brand-name prices are hundreds to over $1,200 more per fill than current manufacturer-direct self-pay prices
• FDA warning letter, February 2026, over compounded drug marketing
• Similar brand-comparison language remains on a live page six months later
• Two of three citations on its pricing page don't support their claims
• No maintenance treatment below BMI 27 — the program ends when it works
• Age cap at 65
• Not available in 15 states plus D.C., including California
• No insurance accepted
• Support is weekdays 9–5 Eastern only
• Published $150 transfer fee before prescription issuance; limited refund rights after prescribing/shipping
• Three company names and two conflicting legal systems in its own contracts
• Only 53 of its 2,058 Trustpilot reviews were posted in the past year, and the profile is merged

So what should you actually do?

If you want a low-cost daily compounded injection, you're 18–65 with a BMI of 27 or higher, you live in a covered state, and you've read everything above — Levity is a reasonable choice. For most other situations, something else fits better.

Find yourself in this table:

🎯 Ready to move?

If Levity fits after everything you just read — go straight to Levity and check availability in your state. We don't earn a cent from that, and we're telling you anyway, because this page exists to help you decide, not to steer you.

If you want brand-name medication with insurance help: Ro lists FDA-approved options, manufacturer-level cash pricing, a free coverage checker, and prior-authorization support. The membership is $39 for month one, then $149 month to month or as low as $74 a month with an annual plan paid upfront. Medication costs extra. Check your coverage with Ro

If you want provider choice or Costco-member care-program pricing: Sesame starts at $59 a month with an annual plan, includes ongoing care from a provider you choose, and charges separately for medication. See current pricing at Sesame Care

If you want a weekly cash-pay compounded route instead of a daily one: → Check the current Embody program details

A licensed clinician decides whether any treatment is appropriate for you. Provider claims, availability, medication, coverage, and price are not guaranteed until confirmed for your case and shown at checkout.

11 things to check before you pay Levity — or anyone

Print this. Use it on any GLP-1 provider, not just this one. It's free and it's yours.

1. What exactly is the medication? Get the drug name in writing.
2. Is it compounded or FDA-approved? These are different products with different safety processes.
3. Daily or weekly? Ask directly. Don't assume.
4. What's the concentration in mg/mL? And what does your dose equal on the syringe you're sent?
5. Which licensed pharmacy is filling it? Get the name and check it's licensed in your state.
6. What is the exact first charge? Screenshot it.
7. What is the exact recurring charge? Screenshot that too.
8. What date does the next order start processing? Put it in your calendar.
9. What's the last moment you can cancel? Both the order and the subscription.
10. Are labs, supplies, shipping, and clinician messages included? Get it in writing.
11. What happens when it works? Ask what the plan is once you hit your goal, and whether they'll keep prescribing.

If a provider makes any of these hard to answer, that's your answer.

How we researched this Levity GLP-1 review

We built this page from primary sources: the FDA's own warning letter database, Florida's pharmacy license records, the federal NPI provider registry, published drug labels and manufacturer pricing pages, and Levity's own website, help center, and contracts. We used customer reviews for service themes only — never as evidence about safety or effectiveness.

Who wrote this

Weight Loss Provider Guide. No physician wrote or reviewed this page, and we're not going to pretend otherwise or invent a credential to make it look more official. This is careful independent research and document verification, not medical advice. Talk to a licensed clinician about your own treatment.

What we checked, and on what date

On August 13, 2026 we read Levity's homepage, FAQ page, About page, product cards, liraglutide pricing article, help center, Terms of Use, and Terms of Sale. We pulled the FDA's February 20, 2026 warning letter from fda.gov. We checked Florida pharmacy license records, the federal NPI registry, and published cash prices at NovoCare Pharmacy and LillyDirect. We reviewed Levity's Trustpilot profile. We looked up all three scientific citations on Levity's liraglutide pricing page.

What we did NOT do

We did not enroll as a patient. We did not pay Levity. We did not receive, test, or inspect any medication. We did not see a patient-specific label. We did not time a clinician's response. We did not test cancellation from inside a paid account. We have no relationship with Levity, and Levity did not review or approve this page.

What still needs verification

We'd rather show you the gaps than hide them:

• Whether Levity has responded to the FDA; the FDA warning-letter page did not display a public close-out letter when we checked on August 13, 2026, which is not the same as saying no response exists
• The M.D. versus D.O. credential mismatch — needs Levity's explanation
• Why one help article says $225 while the homepage says $179
• Whether the $150 transfer fee, still published in Terms of Use last revised December 2023, is being enforced on current orders
• Which pharmacy fills any given order, and the exact formula you'd receive

Our sources

• FDA Warning Letter, Levity Inc. dba Levity, MARCS-CMS 717990, February 20, 2026
• FDA press announcement, warning letters to 30 telehealth companies over compounded GLP-1 marketing, March 3, 2026
• FDA, Compounding and FDA: Questions and Answers; semaglutide shortage resolution and enforcement-discretion dates; dosing-error alert for compounded injectable semaglutide; concerns about unapproved GLP-1 drugs
• Levity homepage, About page, product pages, liraglutide cost article, eligibility and maintenance help pages
• Levity Terms of Use, Terms of Sale, cancellation/refund help pages, and $225 pricing help article
• Florida Department of Health primary-source license verification — PS56867, PH31739, PH33996
• CMS NPI Registry — NPI 1780944918
• NovoCare Wegovy savings and self-pay terms and NovoCare Ozempic self-pay terms
• LillyDirect Zepbound pricing and LillyDirect Mounjaro pricing
• Ro pricing and Ro coverage checker
• Embody official program page
• Sesame online weight-loss program
• Trustpilot — Levity merged profile and recent reviews
• PubMed — STEP 1 extension and SURMOUNT-4 withdrawal studies; the three papers cited on Levity's liraglutide page

Corrections

Found something wrong? Tell us and we'll fix it and note the date. We'd rather be corrected than be confidently wrong. This page is scheduled for re-verification every 30 days for its first three months, then quarterly.

Levity GLP-1 reviews: your questions answered

Is Levity legit? Yes, in the sense that it is traceable: Levity names clinicians and pharmacies, and we confirmed the Florida records for its pharmacist (PS56867) and two pharmacies. Levity itself describes its role as a nonclinical platform that contracts with an independent provider group. "Legitimate" still isn't the same as "FDA-approved" or "right for you," and Levity received an FDA warning letter in February 2026 over its marketing.

How much does Levity cost? Its compounded liraglutide article shows $179 per cycle, or $129 for the first cycle with code WELCOME. Brand-name cards show $1,199 for Ozempic, $1,299 for Mounjaro, and $1,599 for Wegovy per roughly four-week cycle. A separate Levity help article says $225 per month for an all-inclusive subscription, so confirm your actual checkout terms before paying.

Does Levity still sell compounded semaglutide? No. Levity says sales ended April 30, 2025 and active subscriptions were automatically cancelled. Older Levity coverage can still describe that discontinued program.

Is Levity's medication a daily or weekly injection? The low-cost compounded liraglutide is daily. Levity's listed brand-name options — Wegovy, Ozempic, and Mounjaro — are weekly. Saxenda is daily, but Levity's page was marked out of stock when checked. This catches a lot of people off guard.

Is Levity FDA approved? The FDA doesn't approve a telehealth company — it approves specific drug products. Levity's compounded liraglutide is not FDA-approved. Wegovy, Ozempic, Mounjaro, and Saxenda are separately approved finished products, but each has its own indication and label. Levity's Saxenda page was marked out of stock when checked.

Did the FDA shut Levity down? No. The February 20, 2026 letter cited misleading marketing claims and gave Levity 15 working days to respond. It did not order a shutdown, a recall, or state that anyone was harmed.

Does Levity take insurance? No. Levity is cash-pay only. Check your plan before signing up. Eligible commercially insured patients may pay as little as $25 under Novo Nordisk's current savings terms, but coverage, caps, exclusions, and actual copays vary.

What states does Levity serve? Thirty-five, as of August 13, 2026. It does not serve California, Arizona, North Carolina, Utah, Alabama, Arkansas, Delaware, Idaho, Kansas, Louisiana, Mississippi, New Hampshire, New Mexico, South Carolina, West Virginia, or Washington D.C.

What is Levity's BMI requirement? BMI 27 or higher. Levity also says it does not offer maintenance treatment and stops prescribing when your BMI falls below 27.

Is there an age limit? Yes. Levity's posted policy is 18 to 65.

How do I cancel Levity? Request cancellation through your account at least 48 hours before your next scheduled order date. Cancelling the subscription does not stop an order already processing.

Can I get a refund? Not for changing your mind. Levity's Terms of Sale say medication can only be returned if Levity made an error, misstated the price, or caused a significant delay.

Can I move my prescription to my own pharmacy? Levity's published Terms of Use say yes — for a $150 consultation fee per prescription, requested before the prescription is issued, with the remaining order value refunded.

Is Levity cheaper than buying Wegovy through NovoCare? No, and it isn't close at the published prices. Levity lists $1,599 per roughly four-week cycle. After its current starter offer, NovoCare lists Wegovy 0.25–2.4 mg at $349 per monthly fill and Wegovy HD 7.2 mg at $399, before any separate prescriber or program fee.

Are Levity's reviews trustworthy? They are real service anecdotes, but the headline score is a weak rating of today's U.S. program. Trustpilot showed 4.1 from 2,058 reviews, only 53 in the previous year, and a merged U.S.-and-U.K. profile. The older pool spans different products and policies, and Trustpilot does not tag every review by medication.

Is Levity the same company as ZipHealth? They're closely connected. Levity says the same team is behind both brands, its terms name a ZipHealth provider group, and ZipHealth Inc. is one of the two named pharmacies.

Can I get Saxenda from Levity right now? Levity has a Saxenda product page, but it was marked out of stock when we checked on August 13, 2026. Do not assume a live page means the drug is available.

Is Levity worth it? For a cash-pay adult aged 18–65 with a BMI of 27 or higher, in a covered state, who is fine with a daily injection and understands it is a compounded product — yes, the published $179 recurring price can be fair. For anyone who wants weekly dosing, insurance help, treatment below BMI 27, or brand-name value, no.

Our final verdict on Levity

Levity is traceable. The Florida records we checked were active. The pharmacies are named, and the federal NPI number points to a real provider record. The compounded-drug disclaimer on its liraglutide page clearly says the product is not FDA-approved. This is not an anonymous checkout page.

But the version of Levity many older reviews describe hasn't existed since April 2025. The cheap option is a daily injection now, not a weekly one. The brand-name options cost hundreds to over $1,200 more per fill than current manufacturer-direct examples. The $179 and $225 all-inclusive price messages do not line up. The FDA sent a warning letter in February 2026, and similar brand-comparison language remains live six months later. And Levity says the program stops once your BMI falls below 27.

None of that makes Levity a scam. It makes Levity a company you should choose on purpose, after reading the fine print — not because a banner said $129.

If you fit the narrow profile, go for it, and screenshot everything on your way through checkout. If you don't, you've just saved yourself a bad month and possibly a lot of money. Either way, you made the call with the actual facts in front of you.

That's what this page was for.

Still not sure which GLP-1 program is right for you? Take our free 60-second matching quiz.

Weight Loss Provider Guide is an independent comparison resource for GLP-1 telehealth providers. This page is for information only and is not medical advice. The FDA-approved liraglutide, semaglutide, and tirzepatide products discussed here carry boxed warnings about thyroid C-cell tumors and are contraindicated for people with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. Compounded products do not have an FDA-approved label and may differ. Talk with a licensed clinician about whether any treatment is right for you. Prices, policies, and availability change — verify everything before paying.

Last verified: August 13, 2026 · Next scheduled re-verification: September 13, 2026